Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
145.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (2.847%)
Market Cap: £113.79m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Interim Management Statement

20 Oct 2011 07:00

RNS Number : 5036Q
Xaar PLC
20 October 2011
 



  

FOR IMMEDIATE RELEASE

20 October 2011

 

 

 

Xaar plc

 

 

INTERIM MANAGEMENT STATEMENT AND ANALYST DAY

 

 

Xaar plc ("Xaar" or "the Group"), the inkjet printing technology group headquartered in Cambridge, is providing an Interim Management Statement covering trading from 1 July 2011.

 

Revenue and profit for the third quarter of the year were ahead of the Board's expectations. The Board anticipate that this level of trading will continue during Q4, leading to a strong performance for the full year 2011.

 

Sales of Platform 3 ("P3") products in Q3 grew ahead of expectations through the successful completion of the early stages of the capacity expansion programme. This has relieved the short term supply constraint, slightly earlier than anticipated, with the result that P3 revenues are now demand driven. The remaining critical stages of the programme are on track for completion through the fourth quarter of 2011 and the first half of 2012.

 

Sales of Platform 1 ("P1") products have performed in line with expectations, with revenue for Q3 2011 slightly lower than Q2 2011, however forward visibility remains limited.

 

Royalty income for the year to date has increased compared to the same period last year, reflecting, in part, some market share loss to licensees in markets serviced by P1 products.

 

The Group's balance sheet remains strong with net cash at 30 September 2011 of £16.8 million (30 June 2011 - £20.6m, 31 December 2010: £22.0 million). The reduction in net cash reflects planned expenditures related to the capacity expansion.

 

To date, the global economic environment has not impacted Xaar's trading. However, the Board remain cautious and continue to monitor sales channels closely.

 

Today, Xaar is hosting an open day for analysts at its Huntingdon manufacturing facility. The purpose is to update analysts on progress with the capacity expansion and to discuss the markets for its P3 products. No new information will be presented.

 

END

 

CONTACTS

 

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

www.xaar.com

Alex Bevis, Finance Director

Singer Capital Markets Limited:

020-3205-7500

Shaun Dobson

Bankside Consultants:

Simon Bloomfield

020-7367-8888 / 07771-758517

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLBDGGBBBGBC
Date   Source Headline
1st Apr 20202:49 pmRNSTotal Voting Rights
1st Apr 20207:00 amRNSConfirmation of Board Changes and Succession
23rd Mar 20205:47 pmRNSTrading Statement-COVID-19 & Preliminary Statement
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:36 pmRNSPrice Monitoring Extension
13th Mar 20208:41 amRNSHolding(s) in Company
2nd Mar 202011:38 amRNSTotal Voting Rights
25th Feb 20207:41 amRNSHolding(s) in Company
18th Feb 20201:04 pmRNSHolding(s) in Company
13th Feb 20204:57 pmRNSHolding(s) in Company
12th Feb 20205:25 pmRNSHolding(s) in Company
3rd Feb 202012:41 pmRNSTotal Voting Rights
16th Jan 20207:00 amRNSTrading Statement
9th Jan 20207:00 amRNSDirectorate Change
8th Jan 202011:09 amRNSHolding(s) in Company
3rd Jan 20203:32 pmRNSBlock listing Interim Review
2nd Jan 20202:15 pmRNSTotal Voting Rights
10th Dec 20193:51 pmRNSHolding(s) in Company
4th Dec 20194:53 pmRNSCompletion of Investment by Stratasys in Xaar 3D
2nd Dec 20195:39 pmRNSTotal Voting Rights
27th Nov 201910:35 amRNSResult of General Meeting
19th Nov 20199:23 amRNSHolding(s) in Company
18th Nov 20193:32 pmRNSHolding(s) in Company
8th Nov 20194:15 pmRNSPublication - Circular & Notice of General Meeting
1st Nov 201912:50 pmRNSTotal Voting Rights
23rd Oct 20198:30 amRNSHolding(s) in Company
23rd Oct 20198:30 amRNSHolding(s) in Company
11th Oct 20197:00 amRNSCEO Succession
8th Oct 20193:33 pmRNSHolding(s) in Company
8th Oct 20192:46 pmRNSHolding(s) in Company
7th Oct 201912:57 pmRNSGrant of Options
3rd Oct 20191:54 pmRNSHolding(s) in Company
1st Oct 20195:20 pmRNSTotal Voting Rights
1st Oct 20199:10 amRNSHolding(s) in Company
26th Sep 20197:00 amRNSBoard Changes and Succession
26th Sep 20197:00 amRNS2019 Interim Results
12th Sep 20197:00 amRNSProposed investment by Stratasys in Xaar 3D
3rd Sep 20197:00 amRNSTrading update & revised date for interim results
2nd Sep 201910:45 amRNSTotal Voting Rights
1st Aug 201910:39 amRNSTotal Voting Rights
31st Jul 201912:07 pmRNSSecond Price Monitoring Extn
31st Jul 201912:02 pmRNSPrice Monitoring Extension
26th Jul 20199:36 amRNSChange of Auditor
8th Jul 20197:00 amRNSScheduled Trading Statement
4th Jul 20195:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Jul 20193:04 pmRNSTotal Voting Rights
5th Jun 20195:05 pmRNSTotal Voting Rights
28th May 201911:41 amRNSHolding(s) in Company
28th May 20199:08 amRNSHolding(s) in Company
21st May 20193:55 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.